The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

When using glucagon-like peptide-1 drugs (GLP-1s) for weight loss or diabetes, you need to get comfortable with injecting the medication under your skin (subcutaneously). Typically, you will target ...

Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...

Imagine if losing weight were as simple as swallowing a daily pill-no needles, no injections and no anxiety. If you're among the 25 percent of adults who fear needles, per Harvard Health, or if ...

Dr. Jennah Siwak breaks down the factors she and her patients weigh when deciding if GLP-1 medications are the right fit. Glucagon-like peptide-1 (GLP-1) medications, which mimic a natural gut hormone ...

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...

Learn how to store and transport your medication without getting held up at TSA, whether it’s okay to skip a dose and more. ByJudy Koutsky, Contributor. Forbes contributors publish independent expert ...